| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 13 | 0 | 0 | 13 |
| geminin | 16 | 0 | 0 | 16 |
| lamin isoform A-delta10 | 14 | 0 | 0 | 14 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 0 | 3 |
| Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
| vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 12 | 0 | 0 | 12 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
| RAR-related orphan receptor gamma | 8 | 0 | 0 | 8 |
| USP1 protein, partial | 9 | 0 | 0 | 9 |
| NFKB1 protein, partial | 4 | 0 | 0 | 4 |
| Thrombopoietin | 4 | 0 | 0 | 4 |
| AR protein | 19 | 0 | 0 | 19 |
| regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 17 | 0 | 0 | 17 |
| retinoic acid nuclear receptor alpha variant 1 | 14 | 0 | 0 | 14 |
| retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
| farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
| estrogen nuclear receptor alpha | 21 | 0 | 0 | 21 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 7 | 0 | 0 | 7 |
| arylsulfatase A | 8 | 0 | 0 | 8 |
| euchromatic histone-lysine N-methyltransferase 2 | 18 | 0 | 0 | 18 |
| Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
| thyroid hormone receptor beta isoform 2 | 12 | 0 | 0 | 12 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
| muscarinic acetylcholine receptor M1 | 8 | 0 | 0 | 8 |
| Histone deacetylase 3 | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Histone deacetylase 4 | 0 | 3 | 0 | 3 |
| Histone deacetylase 1 | 0 | 5 | 0 | 5 |
| Histone deacetylase 7 | 0 | 3 | 0 | 3 |
| Histone deacetylase 2 | 0 | 5 | 0 | 5 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 3 | 0 | 3 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| Histone deacetylase 8 | 0 | 3 | 0 | 3 |
| Histone deacetylase 6 | 0 | 4 | 0 | 4 |
| Histone deacetylase 9 | 0 | 2 | 0 | 2 |
| Histone deacetylase 5 | 0 | 3 | 0 | 3 |
| ATP-dependent phosphofructokinase | 8 | 0 | 0 | 8 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 2 | 0 | 3 |
| Nitric oxide synthase, brain | 0 | 2 | 0 | 3 |
| Nitric oxide synthase, inducible | 0 | 1 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 1 | 3 |
| Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 6 | 0 | 0 | 6 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| TDP1 protein | 12 | 0 | 0 | 12 |
| Smad3 | 2 | 0 | 0 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 14 | 0 | 0 | 14 |
| G | 11 | 0 | 0 | 11 |
| cytochrome P450 2D6 | 12 | 0 | 0 | 12 |
| IDH1 | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
| NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
| NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
| histone acetyltransferase KAT2A isoform 1 | 7 | 0 | 0 | 7 |
| ATP-binding cassette sub-family C member 3 | 0 | 10 | 0 | 10 |
| Multidrug resistance-associated protein 4 | 0 | 10 | 0 | 11 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
| Potassium channel subfamily K member 2 | 0 | 2 | 2 | 4 |
| Bile salt export pump | 0 | 18 | 0 | 18 |
| Interferon beta | 14 | 0 | 0 | 14 |
| HLA class I histocompatibility antigen, B alpha chain | 11 | 0 | 0 | 11 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 6 |
| Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-2C adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 3 |
| Spike glycoprotein | 8 | 0 | 0 | 8 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 11 | 0 | 0 | 11 |
| Canalicular multispecific organic anion transporter 1 | 0 | 10 | 0 | 10 |
| cytochrome P450 2C9, partial | 11 | 0 | 0 | 11 |
| glucocerebrosidase | 4 | 0 | 0 | 4 |
| DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
| Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
| Type-1A angiotensin II receptor | 0 | 4 | 2 | 6 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
| Type-1 angiotensin II receptor | 0 | 4 | 3 | 9 |
| Type-2 angiotensin II receptor | 0 | 4 | 0 | 4 |
| Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
| Chain A, Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) | 0 | 1 | 0 | 1 |
| EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
| Coagulation factor X | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 4 | 0 | 4 |
| Coagulation factor X | 0 | 5 | 0 | 5 |
| Trypsin-1 | 0 | 2 | 0 | 2 |
| Trypsin-2 | 0 | 2 | 0 | 2 |
| Trypsin-3 | 0 | 2 | 0 | 2 |
| thioredoxin reductase | 10 | 0 | 0 | 10 |
| ATAD5 protein, partial | 6 | 0 | 0 | 6 |
| estrogen-related nuclear receptor alpha | 15 | 0 | 0 | 15 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| GLS protein | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
| DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
| lethal factor (plasmid) | 7 | 0 | 0 | 7 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 4 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
| Glutamate transporter homolog | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 1 | 0 | 6 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 6 | 0 | 7 |
| N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Excitatory amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 2 | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| GTP-binding protein (rab7) | 0 | 0 | 2 | 2 |
| ras protein, partial | 0 | 0 | 2 | 2 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| Rac1 protein | 0 | 0 | 2 | 2 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 2 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 5 |
| Adenosine receptor A1 | 0 | 5 | 0 | 6 |
| Adenosine receptor A2a | 0 | 5 | 0 | 7 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 6 | 1 | 8 |
| Urotensin-2 receptor | 0 | 2 | 0 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Ras-related protein Rab-2A | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 2 | 0 | 7 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 5 | 1 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
| Chain A, Cruzipain | 5 | 0 | 0 | 5 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| GLI family zinc finger 3 | 13 | 0 | 0 | 13 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | 9 | 0 | 0 | 9 |
| pregnane X nuclear receptor | 11 | 0 | 0 | 11 |
| peroxisome proliferator activated receptor gamma | 5 | 0 | 0 | 5 |
| caspase-3 | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| caspase-3 | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 6 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 0 | 4 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 5 | 0 | 7 |
| Chain A, Betaine ABC transporter permease and substrate binding protein | 0 | 0 | 1 | 1 |
| Chain A, Osmoprotection protein (ProX) | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 6 | 0 | 0 | 6 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
| Renin | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 2 | 0 | 2 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 4 | 0 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 1 | 4 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 1 | 1 | 4 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Guanine deaminase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| PPM1D protein | 5 | 0 | 0 | 5 |
| progesterone receptor | 8 | 0 | 0 | 8 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 1 | 4 |
| Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Procathepsin L | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C9 | 0 | 7 | 0 | 7 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
| Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
| Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 5 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 1 | 5 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
| Sodium-dependent serotonin transporter | 0 | 7 | 1 | 8 |
| Sodium-dependent serotonin transporter | 0 | 3 | 1 | 4 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Bifunctional epoxide hydrolase 2 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 4 | 0 | 0 | 4 |
| GABA theta subunit | 5 | 0 | 0 | 5 |
| ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
| Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
| Histamine H2 receptor | 3 | 0 | 0 | 4 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 4 | 0 | 4 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 5 | 0 | 5 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 4 | 0 | 4 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 3 | 0 | 3 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 5 | 0 | 5 |
| P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Coagulation factor XII | 0 | 2 | 0 | 2 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
| Serine protease hepsin | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 3 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| fatty acid synthase | 0 | 1 | 0 | 1 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Thromboxane A2 receptor | 0 | 2 | 1 | 4 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostacyclin receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
| Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Progesterone receptor | 0 | 2 | 1 | 3 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 1 | 1 | 2 |
| Mineralocorticoid receptor | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 1 | 2 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 0 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| polyprotein | 2 | 0 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 0 | 2 | 2 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Integrin beta-1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 1 | 5 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| D | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 1 | 5 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 1 | 3 |
| D(3) dopamine receptor | 0 | 2 | 1 | 5 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 5 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Protease | 0 | 3 | 0 | 3 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 3 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
| Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 2 | 0 | 2 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
| Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
| Chain A, NAD-dependent deacetylase | 0 | 1 | 0 | 1 |
| aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
| Poly [ADP-ribose] polymerase 2 | 0 | 1 | 0 | 1 |
| NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| NAD(+) hydrolase SARM1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase | 0 | 1 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-4 | 0 | 1 | 0 | 1 |
| Voltage-dependent P/Q-type calcium channel subunit alpha-1A | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-3 subunit | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit beta-3 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-7 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-1 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-2 | 0 | 1 | 0 | 1 |
| Voltage-dependent R-type calcium channel subunit alpha-1E | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-4 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-3 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-8 subunit | 0 | 1 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-6 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-4 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-5 subunit | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 1 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 1 | 0 | 2 | 1 | 3 |
| Sodium/glucose cotransporter 2 | 0 | 2 | 1 | 3 |
| Sodium/glucose cotransporter 1 | 0 | 1 | 0 | 1 |
| Sodium/glucose cotransporter 2 | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 28 member 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 5 member 4 | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 0 | 1 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Chain A, Activated Factor Xa Heavy Chain | 0 | 1 | 0 | 1 |
| Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Tyrosine-protein kinase SYK | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 1 | 2 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Sulfate anion transporter 1 | 0 | 0 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 1 | 1 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK3 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PLK2 | 0 | 1 | 0 | 1 |
| Luciferase | 1 | 0 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |